Kras was difficult to target because its structure lacks the deep binding pockets most drugs need.. This happens because kras mutations send a continuous signal to cells, directing them to divide.
Researchers later found that kras switches between an “on” state, which promotes.. In normal cells, kras activation is transient and tightly regulated by upstream growth factors, receptor tyrosine kinases (rtks) and intrinsic negative feedback mechanisms.